Search research articles
Contact Us
Filters
Showing results (171-180 of 235) with videos related to
Page
of 24
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1993
Membrane cofactor protein (CD46) protects cells predominantly from alternative complement pathway-mediated C3-fragment deposition and cytolysis
A Kojima, K Iwata, T Seya, et al.
The Journal of Experimental Medicine
|
June 1, 1992
Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism
T J Oglesby, C J Allen, M K Liszewski, et al.
Advances in Immunology
|
January 1, 1996
Control of the complement system
M K Liszewski, T C Farries, D M Lublin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1985
Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines
J L Cole, G A Housley, T R Dykman, et al.
The Journal of Biological Chemistry
|
August 15, 1997
Membrane cofactor protein (CD46) is a basolateral protein that is not endocytosed. Importance of the tetrapeptide FTSL at the carboxyl terminus
A Maisner, G Zimmer, M K Liszewski, et al.
Clinical and Experimental Immunology
|
February 1, 1991
Characterization of three monoclonal antibodies to membrane co-factor protein (MCP) of the complement system and quantification of MCP by radioassay
S W Cho, T J Oglesby, B L Hsi, et al.
Investigative Ophthalmology & Visual Science
|
December 1, 1993
Differential expression of the complement regulatory proteins in the human eye
N S Bora, C L Gobleman, J P Atkinson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 1, 1983
Identification and partial characterization of the secreted form of the fourth component of human complement: evidence that it is different from major plasma form
A C Chan, K R Mitchell, T W Munns, et al.
Arthritis and Rheumatism
|
July 1, 1973
Bladder toxicity with chronic oral cyclophosphamide therapy in nonmalignant disease
R G Aptekar, J P Atkinson, J L Decker, et al.
Journal of Virology
|
August 1, 1996
The N-glycan of the SCR 2 region is essential for membrane cofactor protein (CD46) to function as a measles virus receptor
A Maisner, J Alvarez, M K Liszewski, et al.
Page
of 24
Search research articles
Search
Showing results (171-180 of 235) with videos related to
Sort By:
Page
of 24
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1993
Membrane cofactor protein (CD46) protects cells predominantly from alternative complement pathway-mediated C3-fragment deposition and cytolysis
A Kojima, K Iwata, T Seya, et al.
The Journal of Experimental Medicine
|
June 1, 1992
Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism
T J Oglesby, C J Allen, M K Liszewski, et al.
Advances in Immunology
|
January 1, 1996
Control of the complement system
M K Liszewski, T C Farries, D M Lublin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1985
Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines
J L Cole, G A Housley, T R Dykman, et al.
The Journal of Biological Chemistry
|
August 15, 1997
Membrane cofactor protein (CD46) is a basolateral protein that is not endocytosed. Importance of the tetrapeptide FTSL at the carboxyl terminus
A Maisner, G Zimmer, M K Liszewski, et al.
Clinical and Experimental Immunology
|
February 1, 1991
Characterization of three monoclonal antibodies to membrane co-factor protein (MCP) of the complement system and quantification of MCP by radioassay
S W Cho, T J Oglesby, B L Hsi, et al.
Investigative Ophthalmology & Visual Science
|
December 1, 1993
Differential expression of the complement regulatory proteins in the human eye
N S Bora, C L Gobleman, J P Atkinson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 1, 1983
Identification and partial characterization of the secreted form of the fourth component of human complement: evidence that it is different from major plasma form
A C Chan, K R Mitchell, T W Munns, et al.
Arthritis and Rheumatism
|
July 1, 1973
Bladder toxicity with chronic oral cyclophosphamide therapy in nonmalignant disease
R G Aptekar, J P Atkinson, J L Decker, et al.
Journal of Virology
|
August 1, 1996
The N-glycan of the SCR 2 region is essential for membrane cofactor protein (CD46) to function as a measles virus receptor
A Maisner, J Alvarez, M K Liszewski, et al.
Page
of 24